Drug Approvals Monthly Update: August 2024 This monthly update of United States (U.S.) Food and Drug Administration (FDA) approvals provides a review of newly approved specialty drugs, new...

As demand for GLP-1a drugs for weight loss has increased, new data provides additional insights about this new class of medications.

New research suggests the clinical benefits of GLP-1 therapies have yet to translate into near-term medical cost savings

Only about 15% of people who began taking GLP-1 drugs such as Wegovy stuck with them after two years